Selective inhibition of HDAC6 promotes bladder cancer radiosensitization and mitigates the radiation-induced CXCL1 signalling

YU-CHIEH TSAIWang, Tzu-YinTzu-YinWangHsu, Chia-LangChia-LangHsuWEI-CHOU LINChen, Jyun-YuJyun-YuChenLi, Jia-HuaJia-HuaLiYEONG-SHIAU PUANN-LII CHENGCHIA-HSIEN CHENGSHENG-FANG SU2023-03-172023-03-172023-02-2100070920https://scholars.lib.ntu.edu.tw/handle/123456789/629356Although trimodality therapy resecting tumours followed by chemoradiotherapy is emerged for muscle-invasive bladder cancer (MIBC), chemotherapy produces toxicities. Histone deacetylase inhibitors have been identified as an effective strategy to enhance cancer radiotherapy (RT).en[SDGs]SDG3Selective inhibition of HDAC6 promotes bladder cancer radiosensitization and mitigates the radiation-induced CXCL1 signallingjournal article10.1038/s41416-023-02195-0368109122-s2.0-85148428324https://api.elsevier.com/content/abstract/scopus_id/85148428324